Pasadena, CA, United States of America

Roger Nani

This inventor holds 1 USPTO granted patent. Top assignee: California Institute of Technology. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger Nani. Retrieved from https://idiyas.com/inventor/roger-nani-8m1c6nas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roger Nani: Innovator in Glycomics and Glycoproteomics

Introduction

Roger Nani is a prominent inventor based in Pasadena, California. He has made significant contributions to the field of glycomics and glycoproteomics. His innovative work focuses on the development of reagents that enhance the study of bacterial glycoproteins.

Latest Patents

Roger Nani holds a patent for a unique reagent known as cysteine hydrazide nicotinamide (Cyhn). This reagent is specifically designed for the enrichment of bacterial glycoproteins. The patent also includes methods for the purification of free oligosaccharides and their subsequent analysis. He has 1 patent to his name, showcasing his commitment to advancing scientific research.

Career Highlights

Roger Nani is affiliated with the California Institute of Technology, where he conducts his research. His work has been instrumental in providing new tools for scientists studying glycoproteins. His contributions have the potential to impact various fields, including biochemistry and molecular biology.

Collaborations

Throughout his career, Roger has collaborated with esteemed colleagues such as William M. Clemons, Jr. and Sergiy Levin. These partnerships have further enriched his research and expanded the scope of his innovations.

Conclusion

Roger Nani is a key figure in the field of glycomics and glycoproteomics, with a focus on developing innovative reagents for scientific research. His work continues to pave the way for advancements in understanding bacterial glycoproteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…